
CAS Number135042-12-5
Synonyms(2R,4R)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid; N-Boc-cis-4-Hydroxy-D-proline; (4S)-4-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-proline; (4R)-4-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-D-proline; (2R,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid; (2R,4R)-N-Boc-4-hydroxy-2-pyrrolidinecarboxylic acid; MFCD02094407
Molecular FormulaC10H17NO5
Molecular Weight231.25
Purity97%
Density1.3±0.1 g/cm3
Boiling Point390.9±42.0 °C at 760 mmHg
Melting Point119-125 °C
Appearancesolid
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 135042-12-5 |
| Catalog No. | 2A-9075820 |
| Chinese Name | N-Boc-顺式-4-羟基-D-脯氨酸 |
| Synonyms | (2R,4R)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid; N-Boc-cis-4-Hydroxy-D-proline; (4S)-4-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-proline; (4R)-4-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-D-proline; (2R,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid; (2R,4R)-N-Boc-4-hydroxy-2-pyrrolidinecarboxylic acid; MFCD02094407 |
| Molecular Formula | C10H17NO5 |
| Molecular Weight | 231.25 |
| Purity | 97 |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 390.9±42.0 °C at 760 mmHg |
| Melting Point | 119-125 °C |
| Appearance | solid |
| Storage Condition | Keep the container sealed and stored in a cool, dr |
| Application | N-Boc-cis-4-hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody drug conjugates (ADC). N-Boc-cis-4-hydroxy-D-proline is also an alkyl chain-based PROTAC linker that can b |
| HTC | 2933990090 |
| PubChem ID | 329766602 |
| MDL Number | MFCD23135644 |
| SMILES | CC(C)(C)OC(=O)N1C[C@@H](O)CC1C(O)=O |
| InChI | 1S/C10H17NO5/c1-10(2,3)16-9(15)11-5-6(12)4-7(11)8(13)14/h6-7,12H,4-5H2,1-3H3,(H,13,14)/t6-,7?/m0/s1 |
| InChI Key | BENKAPCDIOILGV-PKPIPKONSA-N |
| NACRES Code | NA.22 |
| UNSPSC | 12352209 |
| Hazard Symbols | transportation |
| MSDS | msds/75820_1_135042_12_5.pdf |
| Bioactivity | N-Boc-cis-4-Hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-Hydroxy-D-proline is also a alkyl chain-based PROTAC linker that can be used in the synth Related Catalog Research Areas >> Cancer Signaling Pathways >> Antibody-drug Conjugate >> ADC Linker Signaling Pathways >> PROTAC >> PROTAC Linker Target Non-cleavable In Vitro ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. References [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. [2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. Chemical & Physical Properties Density 1.3±0.1 g/cm3 Boiling Point 390.9±42.0 °C at 760 mmHg Melting Point 145ºC Molecular Formula C10H17NO5 Molecular Weight 231.246 Flash Point 190.2±27.9 °C Exact Mass 231.110672 PSA 87.07000 LogP -0.71 Vapour Pressure 0.0±2.0 mmHg at 25°C Index of Refraction 1.531 InChIKey BENKAPCDIOILGV-RNFRBKRXSA-N SMILES CC(C)(C)OC(=O)N1CC(O)CC1C(=O)O Storage condition 2-8°C |
| Use of | N-Boc-cis-4-Hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-Hydroxy-D-proline is also a alkyl chain-based PROTAC linker that can be used in the synth Properties Name Boc-Cis-4-Hydroxy-D-Proline Synonym More Synonyms N-Boc-cis-4-Hydroxy-D-proline Biological Activity Description N-Boc-cis-4-Hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-Hydroxy-D-proline is also a alkyl chain-based PROTAC linker that can be used in the synth Related Catalog Research Areas >> Cancer Signaling Pathways >> Antibody-drug Conjugate >> ADC Linker Signaling Pathways >> PROTAC >> PROTAC Linker Non-cleavable In Vitro ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. References [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. [2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. Chemical & Physical Properties Molecular Formula C10H17NO5 Exact Mass 231.110672 PSA 87.07000 LogP -0.71 Index of Refraction 1.531 InChIKey BENKAPCDIOILGV-RNFRBKRXSA-N |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Purity: 99.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-1-(3-chlorophenyl)ethanol | 135145-34-5 | 2A-9075809 |
| (R)-1-(3-chlorophenyl)ethanol | 120121-01-9 | 2A-9075812 |
| (S)-2-Chloro-1-phenylethanol | 70111-05-6 | 2A-9075815 |
| (S)-(+)-2-Chloro-1-(3,4-methylenedioxyphenyl)ethanol | 313216-50-1 | 2A-9075817 |
| (S)-3-Chloro-4-methoxy-a-methylbenzenemethanol | 124829-13-6 | 2A-9075819 |
| (R)-1-(3,4-dimethoxyphenyl)-2-propanol | 161121-03-5 | 2A-9075821 |
| (R)-1-(4-Fluorophenyl)-1-propanol | 166371-89-7 | 2A-9075823 |
| (R)-1-(3-methoxyphenyl)ethanol | 120523-12-8 | 2A-9075824 |
| 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline | 1167418-13-4 | 2A-9075827 |
| (S)-3-[N-(tert-Butoxycarbonyl)-N-methylamino]pyrrolidine | 169750-01-0 | 2A-9075833 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA